STOCK TITAN

Solid Biosciences (SLDB) Debt by Year

SLDB NASDAQ

Solid Biosciences Inc. held $59.9M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Solid Biosciences Inc. has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $59.9M
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SLDB Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$59.9M-25.3%$80.2M+8.4%$74.0M-52.4%$155.4M+30.4%$119.1M-23.0%$154.7M+103.5%$76.0M-12.0%$86.4M+65.8%$52.1M+578.3%$7.7M

SLDB Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$159.4M+14.7%$297.1M+41.1%$59.9M-25.3%$61.4M-4.7%$138.9M+44.9%$210.6M+79.1%$80.2M+8.4%$64.4M+31.3%$95.9M+4.7%$117.6M-28.6%$74.0M-52.4%$49.0M+0.5%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Solid Biosciences Inc. financials

Frequently Asked Questions

What was Solid Biosciences Inc.'s long-term debt in fiscal year 2025?

Solid Biosciences Inc. held $59.9M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.

What does long-term debt mean on a financial statement?

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Solid Biosciences Inc. (SLDB) reported on that line in every period on record.